Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | Precision oncology in endometrial cancer

Alexandra Leary • 23 Oct 2021
ESGO 2021
Endometrial Cancer Gynecological Cancer

Alexandra Leary, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses where we are in terms of precision medicine for patients with endometrial cancer. Precision medicine uses genetic or molecular profiling to optimize efficiency or therapeutic benefit for patients with endometrial cancer, highlighting the use of immune checkpoint inhibitors in mismatch repair deficient patients. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Alexandra Leary

1:42
Future of precision medicine in endometrial cancer
Alexandra Leary • 23 Oct 2021
1:19
Novel immunotherapy-based combination approaches in cervical cancer
Alexandra Leary • 23 Oct 2021
0:37
Importance of understanding molecular subtypes in endometrial cancer
Alexandra Leary • 23 Oct 2021
6:37
Highlights from ESMO 2020 in gynecological cancers
Alexandra Leary • 24 Sep 2020

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals